Clinical Trial Update: Single and Multiple Ascending Oral Doses of Avenanthramide [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers single and multiple ascending oral doses of avenanthramide in a Phase 1/2 study for inflammation. The trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation

Drugs mentioned

• Avenanthramide (avenanthramide)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Inflammation | Phase 1, Phase 2 | Status: COMPLETED